Login / Signup
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin.
Mei Qiu
Published in:
Annals of internal medicine (2022)
Keyphrases
</>
type diabetes
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
cardiovascular disease
insulin resistance
patient reported outcomes
metabolic syndrome
skeletal muscle